Search - tctmd.com

Displaying 1 - 20 of 61

Sort: Relevancy | Date

News Conference News AHA 2016

全国数据认为 PCI 在没有外科手术后备支援的中心“可能实施”

Yael L. Maxwell

November 16, 2016

News Conference News AHA 2016

Según Datos a Nivel Nacional, las PCI realizadas en Centros Sin Soporte Quirúrgico ‘Probablemente No Tengan Problemas’

Yael L. Maxwell

November 16, 2016

News Conference News AHA 2016

PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests

Yael L. Maxwell

November 16, 2016

Presentation TCT 2016

When Everything Has Disappeared: Role of Cell-Based Engineered Tissue and Organ Transplantation.

Presenter: Timothy D. Henry, Amit N. Patel, Doris A. Taylor

October 31, 2016

Presentation TCT 2016

When Cells are Not Enough: Role of Cellular and Non-Cellular Injectable Biomaterials

Presenter: Timothy D. Henry, Amit N. Patel

October 31, 2016

Presentation TCT 2016

Improving Translational Science In Cardiac Regenerative Medicine. Utility of Animal Models

Presenter: Timothy D. Henry, Amit N. Patel, Steven A.J. Chamuleau

October 31, 2016

Presentation TCT 2016

Obtaining Informed Consent: The Essentials and How to Succeed in Difficult Scenarios

Presenter: David A. Cox, Thomas D. Stuckey, Timothy D. Henry

October 30, 2016

News Daily News

STEMI Patients Far From PCI Centers Fare Well With Pharmacoinvasive Strategy

L.A. McKeown

October 05, 2016

News Conference News ACC 2016

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

Michael O'Riordan

April 04, 2016

News Daily News

研究表明，非罪犯血管血运重建可改善STEMI患者健康状况

Todd Neale

November 04, 2015

News Daily News

Un Estudio Sugiere que la Revascularización de Arterias No Causantes Mejora el Estado de Salud de Pacientes STEMI

Todd Neale

November 04, 2015

News Daily News

Study Suggests Nonculprit Revascularization Enhances Health Status of STEMI Patients

Todd Neale

November 04, 2015

Presentation TCT 2015

First-in-Man Experience With Human Embryonic Stem Cell-Derived Progenitors for Heart Failure

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Philippe Menasché

October 15, 2015

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? For Limb Ischemia There Are Knowns and Unknowns!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Amit Patel

October 15, 2015

$Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!$

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? Yes, Mesenchymal Cells Are Ready to Be Tested for Prevention and Treatment of Chronic Ischemic and Nonischemic Heart Failure!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Emerson C. Perin

October 15, 2015

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? Yes, in STEMI Bone Marrow Mononuclear Fraction Is Ready, and Other Options Are Coming!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Ricardo Sanz-Ruiz

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

Presenter: Nabil Dib, Philippe Menasché, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

Disappointing Clinical Trial Experiences to Date: Should We Continue? In Which Setting? How?

Presenter: Francisco Fdez-Aviles, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

Stem Cells in Biology of the Adult Myocardium: Are Biomaterials the Missing Link?

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Jay H Traverse

October 15, 2015

Advertisement

全国数据认为 PCI 在没有外科手术后备支援的中心“可能实施”

Según Datos a Nivel Nacional, las PCI realizadas en Centros Sin Soporte Quirúrgico ‘Probablemente No Tengan Problemas’

PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests

When Everything Has Disappeared: Role of Cell-Based Engineered Tissue and Organ Transplantation.

When Cells are Not Enough: Role of Cellular and Non-Cellular Injectable Biomaterials

Improving Translational Science In Cardiac Regenerative Medicine. Utility of Animal Models

Obtaining Informed Consent: The Essentials and How to Succeed in Difficult Scenarios

STEMI Patients Far From PCI Centers Fare Well With Pharmacoinvasive Strategy

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

研究表明，非罪犯血管血运重建可改善STEMI患者健康状况

Un Estudio Sugiere que la Revascularización de Arterias No Causantes Mejora el Estado de Salud de Pacientes STEMI

Study Suggests Nonculprit Revascularization Enhances Health Status of STEMI Patients

First-in-Man Experience With Human Embryonic Stem Cell-Derived Progenitors for Heart Failure

Debate: Are We Really Ready for Phase III Trials? For Limb Ischemia There Are Knowns and Unknowns!

Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!

Debate: Are We Really Ready for Phase III Trials? Yes, Mesenchymal Cells Are Ready to Be Tested for Prevention and Treatment of Chronic Ischemic and Nonischemic Heart Failure!

Debate: Are We Really Ready for Phase III Trials? Yes, in STEMI Bone Marrow Mononuclear Fraction Is Ready, and Other Options Are Coming!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

Disappointing Clinical Trial Experiences to Date: Should We Continue? In Which Setting? How?

Stem Cells in Biology of the Adult Myocardium: Are Biomaterials the Missing Link?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content